Finally, with regard to the impact of low BMI on external validity, this may also be seen as a strength, more certainly attributing the reduced incretin effect to diabetes, as obesity itself has also been shown to deteriorate the incretin effect.23 This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.